Clinical trials for Vitreoretinopathy
4 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPHASE1, PHASE2NCT06033703Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal DetachmentMassachusetts Eye and Ear Infirmary · PI: Leo Kim, MD, PhD
- RECRUITINGPhase 2NCT06541574Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) TrialCincinnati Eye Institute, Southwest Ohio
- RECRUITINGPhase 2NCT05523869Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment with Proliferative VitreoretinopathyUnity Health Toronto
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT05660447A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVRWills Eye · PI: Jason Hsu, MD